Daccord Cécile, Touilloux Brice, Von Garnier Christophe
Service de pneumologie, Département de médecine, CHUV, 1011 Lausanne.
Rev Med Suisse. 2020 May 6;16(692):933-938.
Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.
许多哮喘或慢性阻塞性肺疾病（COPD）患者可能感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）。尽管数据有限，但重度和/或未得到控制的哮喘患者以及COPD患者似乎发生更严重新型冠状病毒肺炎（COVID-19）感染病程的风险更高。尽管疫情仍在持续，但哮喘和COPD的常规管理建议仍然有效。然而，在COVID-19大流行期间，由于在操作过程中存在病毒气溶胶化和传播的潜在风险，应谨慎进行肺功能测试和雾化治疗。必须特别注意识别和保护特别易受COVID-19感染的患者。应继续进行哮喘和COPD治疗并加以调整，以确保在整个疫情期间对肺部疾病进行最佳控制，从而降低发生严重COVID-19疾病的风险。
